ICCC vs BIIB: Which Stock is Better?
Side-by-side comparison of Immucell Corp and Biogen Inc in 2026
ICCC
Immucell Corp
$7.54
BIIB
Biogen Inc
$176.02
Key Metrics Comparison
| Metric | ICCC | BIIB | Winner |
|---|---|---|---|
| Market Cap | $68.76M | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | -0.0% | -0.1% | ICCC |
| Gross Margin | 41.4% | 78.9% | BIIB |
Analyze ICCC
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ICCC or BIIB a better investment?
Comparing ICCC and BIIB: Immucell Corp has a market cap of $68.76M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ICCC and BIIB?
ICCC (Immucell Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ICCC or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ICCC or BIIB?
ICCC has higher revenue growth at -0.0% vs -0.1% for BIIB.
Which company is more profitable: ICCC or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 41.4% for ICCC.
Which is the larger company: ICCC or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $68.76M for ICCC.
Should I buy ICCC or BIIB in 2026?
Both ICCC and BIIB have investment merit. ICCC trades at $7.54 while BIIB trades at $176.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ICCC and BIIB stock?
Key differences: Market Cap ($68.76M vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (-0.0% vs -0.1%), Gross Margin (41.4% vs 78.9%).